ArticleEuropean journal of immunology2025

Activation of CD8⁺ T Cells in the Human Ex Vivo Lung Tumor Microenvironment Using Anti-CD3/CD28 and Nivolumab.

Tonia Bargmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.